These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24039897)

  • 1. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
    Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
    PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
    Dimri M; Kang M; Dimri GP
    Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
    Gergely JE; Dorsey AE; Dimri GP; Dimri M
    Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
    Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
    Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.
    Heydari K; Saidijam M; Sharifi MR; Dermani FK; Soleimani Asl S; Shabab N; Najafi R
    Pathol Oncol Res; 2018 Jan; 24(1):145-151. PubMed ID: 28411308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of miR-200c in colorectal cancer through BMI1.
    Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R
    J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
    Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
    J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
    Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
    Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
    Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
    Wang X; Zhu J
    Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
    Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
    J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
    PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 Functions as a Competing Endogenous RNA to Regulate BMI1 Expression by Sponging miR-200c/miR-203 in the Control of the Differentiation of Pulp Cells.
    Jin H; Zhao J; Li C
    Biochem Genet; 2021 Oct; 59(5):1260-1277. PubMed ID: 33772374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
    Dimri M; Cho JH; Kang M; Dimri GP
    J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells.
    Hisamori S; Mukohyama J; Koul S; Hayashi T; Rothenberg ME; Maeda M; Isobe T; Valencia Salazar LE; Qian X; Johnston DM; Qian D; Lao K; Asai N; Kakeji Y; Gennarino VA; Sahoo D; Dalerba P; Shimono Y
    J Gastroenterol; 2022 Jun; 57(6):407-422. PubMed ID: 35244768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
    Kopp F; Oak PS; Wagner E; Roidl A
    PLoS One; 2012; 7(11):e50469. PubMed ID: 23209748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1.
    Sun Q; Liu T; Yuan Y; Guo Z; Xie G; Du S; Lin X; Xu Z; Liu M; Wang W; Yuan Q; Chen L
    Int J Cancer; 2015 Mar; 136(5):1003-12. PubMed ID: 25044403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.